Dendritic Cells Require PINK1-Mediated Phosphorylation of BCKDE1α to Promote Fatty Acid Oxidation for Immune Function

por Basit, Farhan, de Vries, I. Jolanda M.
Publicado 2019

Primary Human Blood Dendritic Cells for Cancer Immunotherapy—Tailoring the Immune Response by Dendritic Cell Maturation

por Sittig, Simone P., de Vries, I. Jolanda M., Schreibelt, Gerty
Publicado 2015

STATing the importance of immune modulation by platinum chemotherapeutics

por Hato, Stanleyson V., de Vries, I. Jolanda M., Lesterhuis, W. Joost
Publicado 2012

Human Dendritic Cell Subsets Undergo Distinct Metabolic Reprogramming for Immune Response

por Basit, Farhan, Mathan, Till, Sancho, David, de Vries, I. Jolanda M.
Publicado 2018

Naturally circulating dendritic cells to vaccinate cancer patients

por Bol, Kalijn F., Tel, Jurjen, de Vries, I. Jolanda M., Figdor, Carl G.
Publicado 2013

Attacking Tumors From All Sides: Personalized Multiplex Vaccines to Tackle Intratumor Heterogeneity

por Fennemann, Felix L., de Vries, I. Jolanda M., Figdor, Carl G., Verdoes, Martijn
Publicado 2019

The Therapeutic Potential of Tackling Tumor-Induced Dendritic Cell Dysfunction in Colorectal Cancer

por Subtil, Beatriz, Cambi, Alessandra, Tauriello, Daniele V. F., de Vries, I. Jolanda M.
Publicado 2021

Paradigm Shift in Dendritic Cell-Based Immunotherapy: From in vitro Generated Monocyte-Derived DCs to Naturally Circulating DC Subsets

por Wimmers, Florian, Schreibelt, Gerty, Sköld, Annette E., Figdor, Carl G., De Vries, I. Jolanda M.
Publicado 2014

The nature of activatory and tolerogenic dendritic cell-derived signal II

por Bakdash, Ghaith, Sittig, Simone P., van Dijk, Tjeerd, Figdor, Carl G., de Vries, I. Jolanda M.
Publicado 2013

Improving cancer immunotherapy by targeting the STATe of MDSCs

por de Haas, Nienke, de Koning, Coco, Spilgies, Lisanne, de Vries, I. Jolanda M., Hato, Stanleyson V.
Publicado 2016

Innate Lymphoid Cells in Tumor Immunity

por van Beek, Jasper J. P., Martens, Anne W. J., Bakdash, Ghaith, de Vries, I. Jolanda M.
Publicado 2016

Immune Curbing of Cancer Stem Cells by CTLs Directed to NANOG

por Wefers, Christina, Schreibelt, Gerty, Massuger, Leon F. A. G., de Vries, I. Jolanda M., Torensma, Ruurd
Publicado 2018

Tailored PGE2 Immunomodulation of moDCs by Nano-Encapsulated EP2/EP4 Antagonists

por Bödder, Johanna, Kok, Leanne M., Fauerbach, Jonathan A., Flórez-Grau, Georgina, de Vries, I. Jolanda M.
Publicado 2023

Harnessing human plasmacytoid dendritic cells as professional APCs

por Tel, Jurjen, van der Leun, Anne M., Figdor, Carl G., Torensma, Ruurd, de Vries, I. Jolanda M.
Publicado 2012

Harnessing the cDC1-NK Cross-Talk in the Tumor Microenvironment to Battle Cancer

por Bödder, Johanna, Zahan, Tasmin, van Slooten, Rianne, Schreibelt, Gerty, de Vries, I. Jolanda M., Flórez-Grau, Georgina
Publicado 2021

An Altered gp100 Peptide Ligand with Decreased Binding by TCR and CD8α Dissects T Cell Cytotoxicity from Production of Cytokines and Activation of NFAT

por Schaft, Niels, Coccoris, Miriam, Drexhage, Joost, Knoop, Christiaan, de Vries, I. Jolanda M., Adema, Gosse J., Debets, Reno
Publicado 2013

The Potential of In Vivo Imaging for Optimization of Molecular and Cellular Anti-cancer Immunotherapies

por Fruhwirth, Gilbert O., Kneilling, Manfred, de Vries, I. Jolanda M., Weigelin, Bettina, Srinivas, Mangala, Aarntzen, Erik H. J. G.
Publicado 2018

Dendritic Cell Cancer Therapy: Vaccinating the Right Patient at the Right Time

por van Willigen, Wouter W., Bloemendal, Martine, Gerritsen, Winald R., Schreibelt, Gerty, de Vries, I. Jolanda M., Bol, Kalijn F.
Publicado 2018

Tumoricidal activity of human dendritic cells

por Tel, Jurjen, Anguille, Sébastien, Waterborg, Claire E.J., Smits, Evelien L., Figdor, Carl G., de Vries, I. Jolanda M.
Publicado 2014

Subsets of CD1c(+) DCs: Dendritic Cell Versus Monocyte Lineage

por Heger, Lukas, Hofer, Thomas P., Bigley, Venetia, de Vries, I. Jolanda M., Dalod, Marc, Dudziak, Diana, Ziegler-Heitbrock, Loems
Publicado 2020